UIUAlIZA r0$GlrltGr$ 1l

Regd. Office:

702,'A' Wing,

Phone: 079 - 65410862

y known as lvee Injectaa Limited)

Chambers, Rasala Marg, Ellisbridge, Ahmed

TEII
380 006.

CIN: 124110GJ

August 13,LOLG
To,

Department of Corporate Services

Bombay Stock Exchange Limited
25th Floor, p. J. Tower,
Dalal Street,
Fort, Mumbai-400 001.
Dear Sir/Madam,

held today
inter alia has

1,.

rter

2.

elnded

for ther year

e Secrertarial
nded on 3i."

office of the company jtloz, 'A' wing, Ashoka chambers, Rasara

Ahmedabad - 380 006 end authorised the directors to send the
r
and to decide other matlters related to the AGM.
Please take

the above on your rlcords.

Thanking You,
Yours faithfully,
For Vivanza Biosciences Limited

+lqrrlv

[.

Harshul K. Shah
Director
DIN:01955747

Registered
Ellisbridge,

of the AGM

ANZA BIOSCIENCES LIMITED

Known as IVEE INJECTAA LTD

_^^(Folmerty
)
Kegrsrered office.702
"A" pving, Asiroka chambers, Rasara Marg,Eilisbridge
, Ahmedabad 380
CIN : 1241 1 0GJ 1 9s2pLCoos057
STATEMENT OF STANDALONE
FINANCIAL RESULTS FOR THE QUARTER ENDED
Particulars

(c) Increase/Decrease

in@

/ (Loss) from operations before

Profit / (Loss) from ordinary activities

/ (Loss) from ordinary activitres

Profit / (Loss) for the period

(1

-{

Share of Profit / ( Loss) of associates "

Net Profit / ( Loss ) after taxeffi

profit/ ( loss ) of associates ( 13 +,t4 +

1S

Earningspershare(b@

s Per Share (after extraordinary iternsl

tnot

1' The above standalone unaudited financial results

was reviewed by the statutory Auditors recommmended
,
by tn1 palo of Directors at their meeting hlro on
saturday
13 Ausust ,
::_cord
? 9.or!gnv operates onry in singre. segment i.e.pharmaceuticars rerated activities

lr::::T1,::.::1t:l:i_.1

.,,r" ,;;il
I/ith
IiS previous
i,"Tlyj:ilfi11lfj:,i:f".Fjl,,:j""ll,*'ttioiqy:;
quarter's/vear's figures have o"un reliJrpuo/rearranged il;i[ior tne quarter ending
- The
*h;;;;; #"""J|:ilil ;:?'Jigl
the current quarter/year.

30, 2016.

5' The company has made preferentiar ailotmeht of 23,62,000

equity shares on 17.06.2016
LIMITE:D

tlc,{

Date : 13/08/2016

W*/'")

: :;l
l

Oflice

GJ\'{ C,A & Co.

Char:tered Accouot*ilt*I',

"o''T'll1lHil;:

*il1;;u:,;l;.35,ry*;,r*

Aurlitor's Report orll.lllaarlne

Qriar.refr rilUeial Resurts and year.ro
IJioscierrccs Ltd. pursua*r
,"nre;o,irl
,

te Results:,of :Vivanza

the. sEBr (Lrsring obrigi

,13.1f
RequirementsJ

Regulationr,ZO f

and,lDisc-losure

lndeperrdent Auditors, Review

Report
To
The Board of Directors,
\ilvanza Biosciences
Ltd.

we lrave reviewed th.t"it::*l"ny[nq

statemenr of standalone unaudited,Fin,ar
Biosciences Ltd. for the
qur.t*r"*nluo-3g*rfune, 20r.6,
attached herewith ,br
conpany pursuant to.thg iequirennent
of
negulation
3i-jr
the sEBI fr,isting obri
Requirenrents) Regut.tiqt,'iOisl
inii
itrt.*."i
*rri.t
is rhe responsibil
h{anagement ind ;pp.;;;l
;;-il.
Boald or uiru.r"r., rr.. been prepared ir
recognition & measuremenr priniiples
raiu down i;-;i;- Accounting standarc
(AS z5I prescribed
secrion
l33 of the conrpanies Acr, 2013
l*.p"rt:e
accepred in";$;
rndia. Our responiiuir'ity is to issue
a reporr

I results of Vivanza

ing submitted by the

tions and Disclosure

of the Company's
accordance with the
for Inte:rim Fihancial
and other accounting
o the statement base{;

:H:'ffigenerally

\{re conducted our review of tlre statement

in aceordance with the standa:rd o Review,Engage
*
a n ci ir rn io' *"iion'?.e rro rm.a
tn. r r a.
!:T,?.:,1:l^
lll:. :i ofSin
t Auditor of
Entiry" fssued by the :f
Institute
charter.a
requifes that we
& perform the review to obtain moderate urrurrn.u-as
to wnether the statJ
t iC free of M
Misslatemenl A review.is rimited primarily to Inquire,
or ine
procedures applied to the financiai data & thus proviae
less assurance tl
performed an Audit & accor:dingly we do not **pr*ri
an Audit opinion.

*.1':l

C
e..ounil.;;fffi;]-iiirr;1",

co*;;;,,

Based on our review conducted as above, nothing has come

to.our attention

t causes us to believil"
in accordance witfff
accounting standards and other recognized accounting practices
unn'po[i.iu has not disclosed ithii,i
information required to be disclosed in terms of Regulation 33 of thilgBf
(Listing; Obligations Eli
Disclpsure RequirementsJ Regulations, 2015 ineluOing the manner in
wtrictr is to tre disclosed, orii
rhat it contains any material misstatement.

that the accompanying statement of unauditud nn"n.irt ,urutis;;;;"

FoT,GMCA&C0.

4g*.ls-Q\
*,/t{tt,t'artlst
1

Place:Ahmedabad
Date; t3th August,

t.il

ttntt'\ .

rrrnnlrr

r,

kwut#
Z0t6

Scanned by CamScanner

Ghartered
FRN:109850W

Amin
Partner
CA.

p No: 108894

VIVANZA BIOSCIENCES LIMITED

(Formerly Known as IVEE INJECTAA LTD

)
Registered office.702 "A" wing, Ashoka chambers, Rasata Marg,Ellisbridge, Ahmedabad
380 0o
CIN : 1241 10GJ1982p1C005057
STATEMENT OF CONSOLIDTE qN{qDITED FINANCIAL RESULTS FOR
THE QUARTER ENDED JUN

30. 201 6.

Quarter Ended

particulars

30/06/201 6

Unaudited
0.0(
0

0.0c
0.0c
0.0c
0.0c
9.93

0.00
4.45

rrur,

J
4
5

rloss, rrom operauons Derore other income, finance costs and exceptional items

Profit / (Loss) from ordinary activities before tin-ance costs and exceotional

14.
(1_2)

-14.3t

itemsllJl

-14.
0.0c
-14.38
0.0c
-14.38
0.0c

Exceptional ltems

10

/ (Loss) f.
IrofI
Tax Expense

I
11

,14.
\Lvrl
Ol^-^

^.

0.00

rvr LrrE PErtgu lt t_ta,

-- \ .

-14.3t
0.0(

Minority Interest *

15

0.00

I Loss , aTrer raxes , mrnonty tnterest and share of profit / ( loss ) of associates ( 13 + 14 + la

-14.38

17

Reserve excluding Revar uation Reserves

as@lEi

18

iarnings Per Share (before extraordinary itemsnnot artnuatiseO;

19.i

\d/ od>ru

-0.5e

fb) Dihrterl

-u.ct

rdry trems, (nol annuailsed):

19.ii
\d./ odstu

-u.ct

(b) Diluled

-0.

Notes:
1. The above consolidate unaudited financial results was reviewed

t y the statutory Au ditors , recommmend

Audit Committee and taken on record by the Board of Directors at tf eir meeting
held c n Saturday 13 August
2. Company operates only in single segment i.e.pharmaceuticals re lated
activities
3. The Siatutory Auditors have carried out a limited review of the finr rncial
results for
5. The Company has made preferential allotment of 23,62,000 equity
sh ares

by the

2016.

tl re quarter ending Jun 30,2016.

on 17.06.201t i and has acquired 10,0 ,000

:quity shares of Vivanza Lifesciences private Limited (formerly Fortune Beverages
Private Limited) (VLPL)by shar swap.
Subsequeni to this, since 17lO6t2O16,VLpL is now a wholly owned subs idiary
of the Comp any . June 30, 2016, bei g the
fisrt quarter in which consolidated accounts are made for t'he Company, pevious quarter
at rd year ended figures ar not
lvailable and provided for.
:NCES LIMITED
Date : 13/08/2016
Place : Ahmedabad

Il

Wy

,)hq'l A

GffcA&{lo.
Office l0t. 'f:attsltranr". $'u.

lf'

Chafterod Ac*ountu,i*- -

Rnslrnri sociaty, Nr.

Lo $howroom, Mirhaklrari six Rc
, E"moil : gmca lg73@ gmail,

, Navrangpura,
m

lndepn*dent AtrtlltorC' Revisw,Repot t

The tr]oard of Dit cctors,:

trNirr*naa flicsciences Li:irrlted
\\te ltavc revi nwed ttr e :rygol parrying
statement of consoli date d unaudi t
Financial results
ci e n c1s. ri y i tI JH;i
ai;;
iTiil
u
n
a
i
$,
sub sid
;;nyj
Cornpany,tThe
:: -l l::
Holoi1u^c.o-nrpanv
,,rhe,,Grol
sur-iai.ry
to
as
"J
for the quarter
its
cnded 30th f une, 11q
2016, attacheJ'herewith, fi-i"g ,"Umitted bt
ng company
pursuant to the requiremen!9f Regulation
ij,ortnJsEBI ()tisring ohHgrri,
and D,isclosure
Regularion, 201s. Thi, utnr.-enr which is rlre responsibi ty of the
Holding
5:::r:::-4rsJ
^i.,
Corn p a ny's bt ana gem enr an d
;i;-;;;
I,]
prepared
ee'n
in
"pp;;;;;
accordance rvith the recognirion
& measurement principtes liia d-o*n
the Accounting
standard for Interim Financial, Reporring
tai isl, ii.i.rin*a.undetr
.on L33 of ,the
companies Act, 2013 read with relevant iuius irrued
iher,eunder or by
lnstitute of ,the
chartered Accountants of India, as applicable and other
accounting'pr nciples generally
accepted in India. our responsibility ir- to irru. a report
on the statem nt based on our

:ll"f:

iiililiftt;rg#d

;;;

;ft;;; ;;;'J

ret'iel!'.

llle conducted our review of the statement in accordance with the s

Engagements (sRE) 24ta "Review of Interim Financial Information

lndependent Auditor of the Entityf issued brythe lnstitute tlf chartered

This standard requires that we plan & perform the review to obtain n
to vrhether the statement is free of Materiat Misititement. A:reviewlis I
lnquires of the Holding company's personnel & analytical procedu
financial data & thus provide less assurance than audit. we havl not pe
accordingly we do not,express an Auditopinion.
The statement includes, the results of the wholly-owned subsidiary, Vi
Private Limited [The Subsidiary CompanyJ

ard bn RevieW
rmed by the
ntants: of India.
[e:assdrance as

ted primarily to
applied, to ,ilre

an,Audit&
nza tifescieniies

We did not review the Interim Financial Results of the Surbsidiary whos Iqggqim Financial
lnformation reflects NIL Revenue & NIL Net Profit after tax for thi,eua r ended 36th
Jirne,
2}16,This interirn financial information of the subsidiary have not been uditeil:fui the
Auditors ratlrcr they have becn signed & declared by the Directors of t C0mpany & orir
reporr on the statement, in so far as it relates to the amounts and,di
res included iir
respect of the $ubsidiary, is based solely on,the Financial statements
ed & declaled by
tire Board of Directors of thc Subsidiary Company.

aii

our review condueted as above, and based orn considerati bf the signecl &
declared Financial Statements referred in thc above paragraph,, nothin has come to gqr
Based on

attention that causes us to bclieve that thc accompanying statement

red in accordaiice
with accounting standards specified under section 133 of the compi es ,{ct, 2,013 read
with rule 7 of the companies (AccountsJ Rules, z0t4 and other ier
';rd accounting

titl: .
lt:ri'3'rl1nlt

.::::

practices and policies

has-not discrosed the information
"tff,re,
requifedto b
Regul ati on 3 3 or
Ap4m;;;'
&
;;s
ctosure
Req,ui
ng

lllrtr

the mahn;ri"',*rti?r.
^r_r_"

rti;''il-[;

frslosea;.oi rhar,ir

Regulationi,
arll1mater,iex

Aeeountahts

Place: Ahmedabad

Date: 13* August,,20L,6

l:r:::,

,.

^'ii:l'

n G Shaikjr

N0:108894